The $15 billion ad-powered AI startup your doctor may already be using
OpenEvidence, founded by Daniel Nadler in 2022, operates an ad-supported AI chatbot that helps doctors search medical journals and clinical guidelines. Nearly two-thirds of US physicians are now using the platform, processing over 42 million prompts monthly. The startup has grown through word-of-mouth adoption in a healthcare sector where few comparable tools have gained similar traction, raising questions about the future of patient care workflows.
Key points
- Reaches ~67% of US doctors with 42M+ prompts monthly
- $15B valuation for ad-supported medical AI platform
- Enables physicians to search journals and clinical guidelines
- Founded in 2022, grown via word-of-mouth in healthcare
Summary and key points written by AI from the headline and a short excerpt, so they can be incomplete or wrong. Ars Technica did the reporting; read the original for the full story.
Read the full story at Ars Technica
